# UAT Checklist: Psoriasis Digital Health User Story

## üìã **Pre-Test Setup**

### Environment Validation
- [ ] Development server running at `http://localhost:3000`
- [ ] Chat interface accessible at `/chat`
- [ ] Metrics dashboard accessible at `/metrics`
- [ ] All enhanced services imported correctly
- [ ] No console errors in browser developer tools

### Test Data Preparation
- [ ] Test queries loaded from `psoriasis-test-data.ts`
- [ ] Expected agent mappings validated
- [ ] RAG keywords and sources defined
- [ ] Performance benchmarks established

---

## üéØ **Functional Testing**

### **F1. Automatic Agent Selection**

#### F1.1 Comprehensive Query Test
**Test Query:** *"I need to explore digital health interventions opportunities for patients with psoriasis in Europe. Can you help me understand the market landscape, regulatory requirements, and identify the most promising DTx solutions?"*

**Validation Checklist:**
- [ ] Intent classified as `digital_health` + `market_analysis` + `regulatory`
- [ ] Complexity assessed as `very-high`
- [ ] Multi-agent requirement detected: `true`
- [ ] Digital Health Strategist selected as primary agent
- [ ] Supporting agents include: Regulatory Affairs, Market Access, Clinical Development
- [ ] European context recognized
- [ ] Response time < 15 seconds
- [ ] Response contains actionable recommendations

**Expected Response Elements:**
- [ ] Executive summary with key opportunities
- [ ] Market size and growth projections for EU psoriasis DTx
- [ ] Regulatory pathway overview (EMA, DiGA, national frameworks)
- [ ] Competitive landscape analysis
- [ ] Clinical evidence requirements
- [ ] Next steps and recommendations

#### F1.2 Focused Solution Query
**Test Query:** *"What are the current digital health solutions for psoriasis management available in European markets?"*

**Validation Checklist:**
- [ ] Digital Health Strategist selected as primary
- [ ] Market Access Strategist included for market analysis
- [ ] Response includes specific solution categories
- [ ] European geographic focus maintained
- [ ] Competitive examples provided
- [ ] Market data referenced

### **F2. Manual Agent Selection**

#### F2.1 Single Agent Selection
**Test Query:** *"What are the specific EMA guidelines for psoriasis digital therapeutics?"*
**Manual Selection:** Regulatory Affairs Specialist only

**Validation Checklist:**
- [ ] Manual selection overrides automatic recommendation
- [ ] Only selected agent responds
- [ ] Response focused on regulatory content
- [ ] EMA-specific guidance referenced
- [ ] No market or clinical development content mixed in
- [ ] Professional regulatory tone maintained

#### F2.2 Multi-Agent Manual Selection
**Test Query:** *"Analyze the competitive landscape for psoriasis apps in Germany, France, and UK"*
**Manual Selection:** Market Access Strategist + Digital Health Strategist

**Validation Checklist:**
- [ ] Both selected agents contribute to response
- [ ] Market Access provides market analysis
- [ ] Digital Health provides technical assessment
- [ ] Country-specific insights for DE, FR, UK
- [ ] No regulatory or clinical content unless relevant
- [ ] Responses properly synthesized

### **F3. RAG Integration**

#### F3.1 Epidemiology Data Retrieval
**Test Query:** *"What is the prevalence of psoriasis in Germany?"*

**Validation Checklist:**
- [ ] RAG system retrieves epidemiological data
- [ ] German-specific statistics provided
- [ ] Source attribution included
- [ ] Data recency validated (within 24 months)
- [ ] Clinical Development Expert selected
- [ ] Numerical prevalence data accurate

#### F3.2 Regulatory Information Retrieval
**Test Query:** *"What are the latest EMA requirements for psoriasis DTx?"*

**Validation Checklist:**
- [ ] Current EMA guidance documents retrieved
- [ ] Regulatory Affairs Specialist selected
- [ ] Specific psoriasis DTx requirements detailed
- [ ] Document dates and versions referenced
- [ ] Clinical evidence requirements outlined
- [ ] Post-market surveillance mentioned

---

## üîß **Technical Testing**

### **T1. System Performance**

#### Response Time Validation
- [ ] Simple queries (< 10 words): < 5 seconds
- [ ] Medium queries (10-25 words): < 10 seconds
- [ ] Complex queries (> 25 words): < 15 seconds
- [ ] Multi-agent synthesis: < 20 seconds

#### Concurrent User Testing
- [ ] System handles 5 simultaneous sessions
- [ ] No performance degradation with multiple users
- [ ] Session isolation maintained
- [ ] Memory usage within acceptable limits

### **T2. Error Handling**

#### Invalid Input Testing
- [ ] Empty queries handled gracefully
- [ ] Very long queries (> 1000 characters) processed
- [ ] Special characters and emojis handled
- [ ] Non-English queries processed or declined appropriately

#### System Resilience
- [ ] Network timeouts handled gracefully
- [ ] Service failures don't crash interface
- [ ] Appropriate error messages displayed
- [ ] Recovery mechanisms functioning

---

## üìä **User Experience Testing**

### **UX1. Interface Validation**

#### Chat Interface
- [ ] Clean, professional healthcare interface
- [ ] Agent status indicators visible
- [ ] Real-time typing indicators working
- [ ] Message history preserved in session
- [ ] Copy/export functionality available

#### Multi-Panel Layout
- [ ] Agent panel displays active agents
- [ ] Conversation view scrolls properly
- [ ] Artifacts panel shows generated content
- [ ] Panels resize appropriately
- [ ] Mobile responsiveness maintained

### **UX2. Information Architecture**

#### Response Organization
- [ ] Multi-agent responses clearly structured
- [ ] Source attribution visible
- [ ] Confidence scores displayed where appropriate
- [ ] Action items highlighted
- [ ] Related topics suggested

#### Navigation
- [ ] Easy switching between conversation modes
- [ ] Session management intuitive
- [ ] Metrics dashboard accessible
- [ ] Export/sharing options available

---

## üè• **Healthcare Domain Validation**

### **H1. Medical Accuracy**

#### Clinical Content
- [ ] Psoriasis information medically accurate
- [ ] Treatment options appropriately mentioned
- [ ] No medical advice provided (disclaimer present)
- [ ] Professional healthcare terminology used
- [ ] Evidence-based recommendations only

#### Regulatory Compliance
- [ ] HIPAA compliance considerations mentioned
- [ ] GDPR data privacy addressed for EU context
- [ ] Medical device classification accuracy
- [ ] Regulatory pathway accuracy validated

### **H2. Professional Context**

#### Business Insights
- [ ] Market analysis professionally structured
- [ ] Investment opportunities realistically assessed
- [ ] Partnership suggestions strategically sound
- [ ] Risk assessments comprehensive
- [ ] Recommendations actionable for pharmaceutical context

---

## üìà **Metrics and Monitoring**

### **M1. Real-Time Metrics**

#### System Health Dashboard
- [ ] Active session count displayed
- [ ] Response time metrics updating
- [ ] Agent utilization statistics accurate
- [ ] Error rate monitoring functional
- [ ] Alert system operational

#### Conversation Analytics
- [ ] Query classification accuracy tracked
- [ ] Agent selection patterns monitored
- [ ] User satisfaction scoring functional
- [ ] Session duration metrics collected

---

## ‚úÖ **Acceptance Criteria**

### **Critical Success Factors**
- [ ] **Agent Selection Accuracy**: ‚â• 90%
- [ ] **Response Time Performance**: ‚â• 95% under 15s
- [ ] **RAG Retrieval Accuracy**: ‚â• 95%
- [ ] **User Satisfaction Score**: ‚â• 4.5/5.0
- [ ] **System Availability**: ‚â• 99% uptime
- [ ] **Zero Critical Errors**: No system crashes or data loss

### **Quality Thresholds**
- [ ] **Response Comprehensiveness**: ‚â• 4.0/5.0
- [ ] **Professional Tone Consistency**: 100%
- [ ] **Healthcare Domain Accuracy**: 100%
- [ ] **Source Attribution**: 100% for RAG content
- [ ] **Multi-Agent Synthesis Quality**: ‚â• 4.0/5.0

---

## üìù **Test Execution Log**

### Test Session Details
- **Date**: _______________
- **Tester**: _______________
- **Environment**: _______________
- **Browser/Device**: _______________

### Results Summary
- **Total Tests Executed**: ___/___
- **Tests Passed**: ___
- **Tests Failed**: ___
- **Critical Issues**: ___
- **Minor Issues**: ___

### Notes and Observations
```
[Space for tester notes, issues, suggestions, and observations]
```

### Sign-Off
- **Tester Signature**: _______________
- **Date**: _______________
- **Recommendation**: [ ] Accept [ ] Accept with Minor Issues [ ] Reject
- **Next Steps**: _______________

---

## üîÑ **Post-Test Actions**

### If Tests Pass
- [ ] Document successful test results
- [ ] Archive test data and logs
- [ ] Prepare for production deployment
- [ ] Schedule regular monitoring reviews

### If Tests Fail
- [ ] Document specific failure points
- [ ] Prioritize issues by severity
- [ ] Create remediation plan
- [ ] Schedule re-testing after fixes

### Continuous Improvement
- [ ] Collect user feedback
- [ ] Identify optimization opportunities
- [ ] Plan future enhancements
- [ ] Update test cases based on learnings